# DICLOFENAC POTASSIUM
> **ANDA213875** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2021-10-19
## Drug
- **FDA Application Number:** ANDA213875
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DICLOFENAC POTASSIUM
- **Generic name:** DICLOFENAC POTASSIUM
- **Active ingredients:** DICLOFENAC POTASSIUM
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2021-10-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213875)
---
*AI Analytics · CC0 1.0*